Platelet to white blood cell ratio predicts 30-day postoperative infectious complications in patients undergoing radical nephrectomy for renal malignancy.

INTRODUCTION We sought to examine the relationship between preoperative platelet to white blood cell ratio (PLT/WBC), a hematological marker of the systemic inflammatory response, and postoperative infectious complications following radical nephrectomy for localized renal cell carcinoma. METHODS We performed a retrospective cohort study of patients treated with radical nephrectomy for localized kidney cancer between January 1, 2005 and December 31, 2014 (n=6235) using the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) database. Univariate and multivariate analyses were used to assess the association between PLT/WBC ratio and 30-day infectious complications, including surgical site infection, urinary tract infection (UTI), pneumonia, and sepsis. Secondarily, we examined major complications and bleeding requiring transfusion. RESULTS A lower PLT/WBC ratio was associated with an increased risk of sepsis, pneumonia, and UTI rates (p<0.05 for all). Furthermore, there was a significant trend of decreasing rates of sepsis and pneumonia with increasing PLT/WBC ratio across quintiles (p<0.05 for all). On multivariate analysis, patients with the lowest PLT/WBC ratios (Quintile 1) had a two-fold risk of having a postoperative infectious complication compared to patients in the highest quintile (odds ratio [OR] 2.01; 95% confidence interval [CI] 1.42-2.86; p<0.0001). Patients in Quintile 5 had a higher risk of requiring blood transfusion than those in Quintiles 2-4 (p<0.05 for all). CONCLUSIONS The PLT/WBC ratio represents a widely available and novel index to predict risk of infectious and bleeding complications in patients undergoing radical nephrectomy. External validation is required and the biological underpinning of this phenomenon requires further study.

[1]  Khawaja H. Bilal,et al.  Utilization trends and outcomes up to 3 months of open, laparoscopic, and robotic partial nephrectomy , 2017, Journal of Robotic Surgery.

[2]  J. Ijzermans,et al.  Perioperative Events and Complications in Minimally Invasive Live Donor Nephrectomy: A Systematic Review and Meta-Analysis , 2016, Transplantation.

[3]  A. Nathens,et al.  Morbidity and Mortality of Radical Nephrectomy for Patients With Disseminated Cancer: An Analysis of the National Surgical Quality Improvement Program Database. , 2016, Urology.

[4]  J. Carmichael,et al.  Outcomes of colon resection in patients with metastatic colon cancer. , 2016, American journal of surgery.

[5]  C. Hannan,et al.  A Systematic Review of the Prognostic Role of Hematologic Scoring Systems in Patients With Renal Cell Carcinoma Undergoing Nephrectomy With Curative Intent. , 2016, Clinical genitourinary cancer.

[6]  M. Arab,et al.  Investigating Preoperative Hematologic Markers for Prediction of Ovarian Cancer Surgical Outcome. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[7]  T. Fabian,et al.  A prospective study of platelet function in trauma patients , 2016, The journal of trauma and acute care surgery.

[8]  K. Safranow,et al.  Inflammation markers are associated with metabolic syndrome and ventricular arrhythmia in patients with coronary artery disease. , 2016, Postepy higieny i medycyny doswiadczalnej.

[9]  C. Ko,et al.  Improved Surgical Outcomes for ACS NSQIP Hospitals Over Time: Evaluation of Hospital Cohorts With up to 8 Years of Participation , 2016, Annals of surgery.

[10]  F. Keeley,et al.  Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons Nephrectomy Audit , 2016, BJU international.

[11]  F. Friedersdorff,et al.  Evaluation of perioperative complications in open and laparoscopic surgery for renal cell cancer with tumor thrombus involvement using the Clavien-Dindo classification. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  T. Klatte,et al.  Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma , 2015, World Journal of Urology.

[13]  R. Tamargo,et al.  Preoperative anemia increases postoperative morbidity in elective cranial neurosurgery , 2014, Surgical neurology international.

[14]  M. Otterstatter,et al.  Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986–2007 , 2014, Cancer Causes & Control.

[15]  R. Breau,et al.  Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus. , 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[16]  D. Quinlan,et al.  Clinico-pathological analysis of renal cell carcinoma demonstrates decreasing tumour grade over a 17-year period. , 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[17]  Mani Menon,et al.  Practice patterns and outcomes of open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: results from the nationwide inpatient sample. , 2014, The Journal of urology.

[18]  Y. Novitsky,et al.  Effect of patient and hospital characteristics on outcomes of elective ventral hernia repair in the United States , 2013, Hernia.

[19]  W. Berry,et al.  Relationship between occurrence of surgical complications and hospital finances. , 2013, JAMA.

[20]  Liang Li,et al.  What are the real rates of postoperative complications: elucidating inconsistencies between administrative and clinical data sources. , 2012, Journal of the American College of Surgeons.

[21]  J. Donohue,et al.  How best to measure surgical quality? Comparison of the Agency for Healthcare Research and Quality Patient Safety Indicators (AHRQ-PSI) and the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) postoperative adverse events at a single institution. , 2011, Surgery.

[22]  S. Herrell,et al.  Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. , 2011, European urology.

[23]  J. Lysaght,et al.  Obesity and post‐operative complications in patients undergoing non‐bariatric surgery , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[24]  Lorenzo Marconi,et al.  EAU guidelines on renal cell carcinoma: 2014 update. , 2010, European urology.

[25]  C. Ko,et al.  Quality improvement in surgery: the American College of Surgeons National Surgical Quality Improvement Program approach. , 2010, Advances in surgery.

[26]  C. Holsapple,et al.  Assessing Surgical Quality Using Administrative and Clinical Data Sets: A Direct Comparison of the University HealthSystem Consortium Clinical Database and the National Surgical Quality Improvement Program Data Set , 2009, American journal of medical quality : the official journal of the American College of Medical Quality.

[27]  P. Giannuzzi,et al.  Comorbidity in patients undergoing coronary artery bypass graft surgery: impact on outcome and implications for cardiac rehabilitation , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[28]  D. McMillan,et al.  Evaluation of an inflammation‐based prognostic score in patients with metastatic renal cancer , 2006, Cancer.

[29]  A. Aljada,et al.  Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation , 2022 .

[30]  W. Jelkmann,et al.  Role of blood platelets in infection and inflammation. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[31]  J. Thornhill,et al.  Incidentally detected renal cell carcinoma: pathological features, survival trends and implications for treatment. , 1996, British journal of urology.

[32]  G. Çiçek,et al.  White blood cell count to mean platelet volume ratio: A novel and promising prognostic marker for ST-segment elevation myocardial infarction. , 2016, Cardiology journal.

[33]  D. K. Choi,et al.  Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival in Renal Cell Carcinoma Patients Undergoing Nephrectomy , 2015, Annals of Surgical Oncology.

[34]  M. Dehghani,et al.  White blood cell count to mean platelet volume ratio as a novel non-invasive marker predicting long-term outcomes in patients with non-ST elevation acute coronary syndrome. , 2015, Cardiology journal.

[35]  D. McMillan,et al.  Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. , 2010, Future oncology.

[36]  G. Odrowąż-Sypniewska,et al.  Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome. , 2007, Advances in medical sciences.

[37]  F. Gottrup An overview of surgical site infections: aetiology, incidence and risk factors , 2005 .